AVEO's Ficlatuzumab in Combination with Gefinitib Well Tolerated in Patients with Non-Small Cell Lung Cancer; Phase 1b Data Presented at ASCO - MarketWatch - http://www.marketwatch.com/story...
Roche - Roche enters collaboration with Bristol-Myers Squibb to study combination therapy with vemurafenib and ipilimumab in advanced skin cancer - http://www.roche.com/media...
RT @Roche_com: News: Roche enters collaboration with Bristol-Myers Squibb to study combination therapy with vemurafenib http://dlvr.it/Tqgs8
- Sally Church
RT @NeuroUroGastro: RT @SympoUrology @SympoGastroEnt: IMRT cuts GI side effects from prostate cancer in half vs 3D-CRT http://bit.ly/lWSR3J
- Sally Church
RT @djsampson: Lovely piece RT @Allochthonous: Why blogs can cover the sciencey parts the mainstream media will never reach http://bit.l ...
- Sally Church